| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |